Zobrazeno 1 - 10
of 59
pro vyhledávání: '"J.H.E. Dambrink"'
Autor:
Elvin Kedhi, Vincent Roolvink, J.H.E. Dambrink, A. W. J. van ’t Hof, Harry Suryapranata, Veemal Hemradj, A T Marcel Gosselink, J. P. Ottervanger
Publikováno v:
European Heart Journal Acute Cardiovascular Care, 9, 5, pp. 462-468
European Heart Journal Acute Cardiovascular Care, 9, 462-468
European Heart Journal Acute Cardiovascular Care, 9, 462-468
Background: The association between chronic beta-blocker treatment and haemodynamics at admission in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention is not well studied. We investigated t
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
A.W.J. van't Hof, Vincent Roolvink, A. T. M. Gosselink, Harry Suryapranata, Erik A Badings, J.H.E. Dambrink, E van 't Riet, R. S. Hermanides, J. P. Ottervanger, E. Kedhi, Wouter Remkes, A Van Der Sluis
Publikováno v:
Netherlands Heart Journal, 27, 2, pp. 73-80
Netherlands Heart Journal, 27, 73-80
Netherlands Heart Journal, 27(2), 73-80. Bohn Stafleu van Loghum
Netherlands Heart Journal
Netherlands Heart Journal, 27, 73-80
Netherlands Heart Journal, 27(2), 73-80. Bohn Stafleu van Loghum
Netherlands Heart Journal
Contains fulltext : 202710.pdf (Publisher’s version ) (Open Access) BACKGROUND: An early invasive strategy (EIS) is recommended in high-risk patients with non-ST-elevation acute coronary syndrome (NSTE-ACS), defined as coronary angiography (CAG), w
Autor:
J. P. Ottervanger, Freek J. Zijlstra, J.H.E. Dambrink, Marcel Gosselink, M.J. de Boer, Cyril Camaro, Harry Suryapranata
Publikováno v:
European Heart Journal. 40
Background The Endothelial Progenitor Cell (EPC) stent was designed to capture circulating EPCs and promote early stent re-endothelization. Erythropoietin (EPO) stimulates mobilization of EPC from the bone marrow. Combination of EPO and the EPC stent
Autor:
J. P. Ottervanger, Sinem Kilic, J.H.E. Dambrink, R. S. Hermanides, A. T. M. Gosselink, Vincent Roolvink, E. Kedhi, A. W. J. van ’t Hof, Evelien Kolkman
Publikováno v:
Netherlands Heart Journal
Aim This study sought to assess whether radial artery access improves clinical outcomes in patients presenting with acute myocardial infarction compared with femoral artery access. Methods This is a single-centre, prospective observational registry o
Autor:
J. M. ten Berg, Harry Suryapranata, A.W.J. van't Hof, Sonja Postma, J. P. Ottervanger, A. T. M. Gosselink, Evelien Kolkman, J.H.E. Dambrink
Publikováno v:
International Journal of Cardiology. 205:31-36
Background Only few data are available on the predictive value of ST deviation (both ST elevation and depression). Therefore, we have examined the predictive value of ST elevation and ST deviation in STEMI patients on 30-day and long term mortality.
Publikováno v:
European Heart Journal. 39
Autor:
A. Ghani, J. C. A. Hoorntje, J.H.E. Dambrink, J. P. Ottervanger, A. W. J. van ’t Hof, A. T. M. Gosselink
Publikováno v:
Netherlands Heart Journal. 20:347-353
There are conflicting data regarding optimal treatment of non-culprit lesions detected during primary percutaneous coronary intervention (PCI) in patients with ST-elevation myocardial infarction (STEMI) and multi-vessel disease (MVD). We aimed to inv
Autor:
R. S. Hermanides, A. W. J. van ’t Hof, A. T. M. Gosselink, Jan Paul Ottervanger, J. C. A. Hoorntje, Freek J. Zijlstra, Harry Suryapranata, M.J. de Boer, J.H.E. Dambrink
Publikováno v:
Thrombosis and Haemostasis, 106(4), 636-640. Georg Thieme Verlag
Thrombosis and Haemostasis, 106, 636-40
Thrombosis and Haemostasis, 106, 4, pp. 636-40
Thrombosis and Haemostasis, 106, 636-40
Thrombosis and Haemostasis, 106, 4, pp. 636-40
SummaryThis is a prospective, observational study performed in all consecutive ST-elevation myocardial infarction (STEMI) patients who had activated clotting time (ACT) measurement on arrival in the cathlab before coronary angiography. We studied the
Autor:
M de Boer, H. Suryapranata, D. A. A. M. Schellings, J. C. A. Hoorntje, A. W. J. van ’t Hof, J.H.E. Dambrink
Publikováno v:
Netherlands Heart Journal, 18, 307-13
Netherlands Heart Journal, 18, 6, pp. 307-13
Netherlands Heart Journal, 18, 6, pp. 307-13
Item does not contain fulltext Background. In patients with unstable angina or non-ST-elevation acute coronary syndrome (NSTE-ACS) who are eligible for PCI, routine stenting is the recommended treatment strategy, based on the opinion of experts. Prov